cell signaling 9165s danvers (Cell Signaling Technology Inc)
96
Structured Review
Cell Signaling Technology Inc
cell signaling 9165s danvers
Cell Signaling 9165s Danvers, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1595 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+signaling+9165s+danvers/c-Jun+Rabbit+mAb/10__1016_slash_j__bcp__2026__117923-88-105-105
Average 96 stars, based on 1595 article reviews
Cell Signaling 9165s Danvers, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1595 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+signaling+9165s+danvers/c-Jun+Rabbit+mAb/10__1016_slash_j__bcp__2026__117923-88-105-105
Average 96 stars, based on 1595 article reviews
cell signaling 9165s danvers - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Incubation:Article Title: Xaliproden improves diabetic kidney disease through JNK-mediated renal tubular protection Article Snippet: Diabetic kidney disease (DKD) is a major diabetic complication and the primary global cause of end-stage renal disease.. Hyperglycemia triggers multiple pathological signaling pathways and ultimately leads to structural alterations and functional decline in the kidney.. Xaliproden is a 5-HT1A receptor agonist originally developed for its neuroprotective effects; however, its impacts on renal disease remain unknown. Article Title: Febuxostat facilitates neovasculogenesis in chronic kidney disease through xanthine oxidase/NADPH oxidase/c-Jun signaling pathways. Article Snippet: The accumulation of uremic toxins in circulation contributes to the cardiovascular diseases that result from chronic kidney disease (CKD).. Indoxyl sulfate (IS), which is a protein-bound uremic toxin, promotes cardiovascular diseases with impaired neovascularization by increasing the reactive oxygen species (ROS).. This study aimed to investigate febuxostat, a potent xanthine oxidase (XO) inhibitor, for its potential effects on the mechanisms of neovasculogenesis in CKD. |